Skip to main content
. 2023 Jan 27;13:1089938. doi: 10.3389/fendo.2022.1089938

Figure 4.

Figure 4

Carbohydrate profile at baseline time (Day 0) and 90 and 180 days post-supplementation. (A) Glycemia. (B) Insulin. (C) HOMA-IR. Novel Nutraceutical Supplement_(S) (n = 30) and Novel Nutraceutical Supplement (n = 29). Values are expressed as mean ± SEM or median (min to max, box plot) by plot violin graphic. HOMA-IR, Homeostatic Model Assessment of Insulin Resistance.